Unveiling the Growing Threat: Australia's Sixth Report on Antimicrobial Use and Resistance
A Call to Action: Addressing the Rising Concern of Antimicrobial Resistance
The Australian Centre for Disease Control (CDC) has released a critical report, shedding light on the alarming rise of antimicrobial resistance (AMR) in the country. This comprehensive report, the Sixth Australian Report on Antimicrobial Use and Resistance (AURA), reveals a 25% increase in critical antibiotic resistance cases in 2024, a statistic that demands immediate attention.
But here's where it gets concerning: Only half of the antibiotics administered post-surgery were deemed appropriate, indicating a potential misstep in medical practice. This highlights the delicate balance between effective treatment and the development of resistance.
The Growing Resistance: A National Concern
AMR occurs when microorganisms, including bacteria, viruses, fungi, and parasites, become resistant to antimicrobial medicines. This resistance makes infections challenging, if not impossible, to treat, posing a significant threat to public health. The AURA report, compiled from data across hospitals, aged care facilities, and the community, paints a comprehensive picture of antibiotic usage and the rapid emergence of resistance.
In 2024, approximately 37.1% of Australians received 23.2 million antibiotic prescriptions under the Pharmaceutical Benefits Scheme, a 4.8% increase from 2023. Alarmingly, this period also witnessed a 25.2% surge in critical antibiotic resistance reports. The CDC spokesperson emphasized the urgency, stating, 'The fact that cases of critical antimicrobial resistance increased by 25% in 2024 and less than half of the antibiotics given after surgeries were appropriate, shows the need for us to focus our attention a lot more strongly in targeted areas.'
Key Findings: A Mixed Bag
The report reveals a mixed picture, with some encouraging trends and others that demand immediate attention.
- Last-Line Antibiotics: 88.1% of these critical antibiotics were prescribed appropriately in hospitals, a positive sign. However, the story changes when it comes to post-surgery antibiotics, with only 45.0% deemed appropriate.
- Aged Care Residents: Older Australians in residential care experienced a 14.4% increase in antimicrobial prescriptions in 2024 compared to 2023. Moreover, 34.7% of antibiotics prescribed to these residents were used for extended periods, exceeding six months.
The Way Forward: Balancing Stewardship and Practice
The AURA report underscores the importance of antimicrobial stewardship, a practice that aims to optimize the use of these medicines. While many stewardship programs are effective, prescribing practices vary widely across different settings. The CDC spokesperson noted, 'Identifying these pressure points – as this analysis has done – is critical if we are to safeguard treatment options for the future.'
The report does not introduce new policies but serves as a crucial evidence base for guiding stewardship, infection prevention, clinical guidelines, and future policy decisions. By detecting risks through concrete data, Australia can take proactive measures to combat AMR before it becomes a pervasive issue.
Access the Report: A Step Towards Awareness
The AURA report is available on the Antimicrobial resistance website (https://www.amr.gov.au/resources/sixth-australian-report-antimicrobial-use-and-resistance-human-health-aura-report-0). This report is a significant step towards raising awareness and fostering a national conversation on AMR, encouraging all stakeholders to work together to safeguard the future of antimicrobial treatment.
